Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hong Kong
Pharma
Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia
Novartis signed a $5.2 billion siRNA deal with Argo. The FDA approved subcutaneous Leqembi. The Hong Kong exchange censured Henlius and its former CEO.
Angus Liu
Sep 5, 2025 9:00am
Visen Pharmaceuticals files for $86M IPO in Hong Kong
Mar 21, 2025 7:05am
Lilly-Innovent, Novartis, Moderna and more—Fierce Pharma Asia
Feb 18, 2022 9:15am
Moderna, Eli Lilly, AstraZeneca and more—Fierce Pharma Asia
Feb 12, 2021 10:45am
An IPO will make one of the world's richest biopharma families
Jun 13, 2019 11:47am
Sanofi flu vaccine cleared in Hong Kong after impurities report
Jan 2, 2019 9:10am
